Chemotherapy pacltacel, carboplatin and etoposide withconcurrent radiotherapy in the treatment of locoregionallyadvanced non small cell lung cancer (NSCLC)

Forty-three patients with locoregionally advanced NSCL was treated, Tumour was radically resected in 30% of patients. Therapeutic response to CR+PR was achieved in 58% pts.; 44% reached a 1-year suvival, 9% two years.